Nicardipine Hydrochloride Injection
Product Images NDC 69097-007

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Nicardipine Hydrochloride (NDC 69097-007). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cipla Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pouch-label-20mg (Pouch Label 20mg)

This is a description of a medication with the NDC 69097-007-45. It contains Nicardipine Hydrochloride in 0.9% Sodium Chloride injection for intravenous infusion. The medication is sterile and nonpyrogenic with a concentration of 20 mg in 200 mL (0.1 mg/mL). The package insert should be consulted for complete information on dosage and administration. It is essential to check for leaks, ensure the solution is clear, avoid adding supplemental medication, and not use in series connections. Storage instructions include keeping it at 21°C to 25°C, protecting from freezing and excessive heat, and storing in the carton until ready to use.*

FDA Label Image

Pouch-label-40mg (Pouch Label 40mg)

This text provides information about a medication containing Nicardipine Hydrochloride in 0.9% Sodium Chloride Injection for intravenous infusion. The medication comes in a 40 mg in 200 mL solution with a concentration of 0.2 mg/mL. It is sterile and nonpyrogenic with iso-osmotic characteristics. The text also includes instructions for usage, dosage, caution regarding leaks, storage conditions, manufacturer details, and a reminder to protect the solution from light.*

FDA Label Image

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.